136 related articles for article (PubMed ID: 26705181)
1. [Significance of C-myc expression in T-lymphoblastic lymphoma/leukemia and its relation with prognosis].
Zhang Y; Li J; Xi Y; Bai W; Bai W; Sun R
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):571-7. PubMed ID: 26705181
[TBL] [Abstract][Full Text] [Related]
2. [Value of CD, MPO, Ki-67 and C-MYC Positive Rate in the Pathological Tissues and C-MYC Gene of Patients with T-LBL/ALL for Predicting Prognosis].
Wu Y; Tang HY; Ding YY; Pan XQ; Tan CM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):110-115. PubMed ID: 29397827
[TBL] [Abstract][Full Text] [Related]
3. [Significance of microRNA-16 and bcl-2 expression in T lymphoblastic lymphoma/leukemia and its relation with prognosis].
Li J; Li P; Wang JF; Xi YF
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):748-52. PubMed ID: 24447552
[TBL] [Abstract][Full Text] [Related]
4. State of chromosome 11q23 in T-ALL/LBL and their relation to prognosis.
Wang JF; Li J; Xi YF; Bai W
Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):375-80. PubMed ID: 22710816
[TBL] [Abstract][Full Text] [Related]
5. [C-MYC Gene and Protein Expression in Paraffin Wax of T Lymphoblastic Lymphoma and Leukemia Patients and Its Effect on the Prognosis].
Zhang XD; He LM; Ma L; Chang ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):141-145. PubMed ID: 29397833
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic study of 128 cases of T-lymphoblastic lymphoma/leukemia].
Yu B; Du JR; Xie JL; Yu R; Zheng XD; Zhu H; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):452-7. PubMed ID: 21055173
[TBL] [Abstract][Full Text] [Related]
7. [Expression of miR-16 in patients with T lymphoblastic lymphoma/acute lymphoblastic leukemia].
Tong LG; Wu WZ; Zhang YP; Zhou ZG; Chen YF; Huang WJ; Xu H; Su QQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):99-103. PubMed ID: 24598659
[TBL] [Abstract][Full Text] [Related]
8. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
9. [Mediastinal T lymphoblastic lymphoma/leukemia: clinicopathological and prognostic analyses of 61 cases].
Gao XZ; Wei JG; Li SL; Han J; Wang GN; Li WC
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):601-606. PubMed ID: 32486538
[No Abstract] [Full Text] [Related]
10. TDT (-), KIT (+), CD34 (+), CD99 (+) precursor T lymphoblastic leukemia/lymphoma.
Terada T
Int J Clin Exp Pathol; 2012; 5(2):167-70. PubMed ID: 22400079
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features of T-lymphoblastic lymphoma with Langerhans cell histiocytosis in the same lymph node].
Liu F; Rao HL; Guo N; Guo L; Lyu J; Hu WW; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2020 Feb; 49(2):149-155. PubMed ID: 32074728
[No Abstract] [Full Text] [Related]
13. High levels of bcl-2 protein expression do not correlate with genetic abnormalities but predict worse prognosis in patients with lymphoblastic lymphoma.
Gu Y; Pan Y; Meng B; Guan B; Fu K; Sun B; Zheng F
Tumour Biol; 2013 Jun; 34(3):1441-50. PubMed ID: 23494176
[TBL] [Abstract][Full Text] [Related]
14. [Impact of PRDM1 gene inactivation on C-MYC regulation in diffuse large B-cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Pang XL; Chen R; Wang L; Zhang W; Li XX
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):25-31. PubMed ID: 29325247
[No Abstract] [Full Text] [Related]
15. Characterization of childhood precursor T-lymphoblastic lymphoma by immunophenotyping and fluorescent in situ hybridization: a report from the Children's Oncology Group.
Smock KJ; Nelson M; Tripp SR; Sanger WG; Abromowitch M; Cairo MS; Perkins SL;
Pediatr Blood Cancer; 2008 Oct; 51(4):489-94. PubMed ID: 18618503
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features and prognosis of T lymphoblastic lymphoma associated with Langerhans cell histiocytosis].
Li X; Wang Y; Chen R; Abulaiti D; Ma Z; Miao N; Abulajiang G; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):522-7. PubMed ID: 25346121
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous involvement in lymphoblastic lymphoma.
Chimenti S; Fink-Puches R; Peris K; Pescarmona E; Pütz B; Kerl H; Cerroni L
J Cutan Pathol; 1999 Sep; 26(8):379-85. PubMed ID: 10551409
[TBL] [Abstract][Full Text] [Related]
18. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
19. MYC Expression Is Associated With p53 Expression and TP53 Aberration and Predicts Poor Overall Survival in Acute Lymphoblastic Leukemia/Lymphoma.
Gao L; Harbaugh B; Parr K; Patel P; Golem S; Zhang D; Woodroof J; Cui W
Am J Clin Pathol; 2022 Jan; 157(1):119-129. PubMed ID: 34528662
[TBL] [Abstract][Full Text] [Related]
20. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
